Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Comparing Prescribing and Dispensing Data of the PCORnet Common Data Model Within PCORnet Antibiotics and Childhood Growth Study.

Lin PD, Daley MF, Boone-Heinonen J, Rifas-Shiman SL, Bailey LC, Forrest CB, Horgan CE, Sturtevant JL, Toh S, Young JG, Block JP; PCORnet Antibiotics and Childhood Growth Study Group.

EGEMS (Wash DC). 2019 Apr 12;7(1):11. doi: 10.5334/egems.274.

2.

Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research.

Toh S, Wellman R, Coley RY, Horgan C, Sturtevant J, Moyneur E, Janning C, Pardee R, Coleman KJ, Arterburn D, McTigue K, Anau J, Cook AJ.

Clin Epidemiol. 2018 Nov 27;10:1773-1786. doi: 10.2147/CLEP.S178163. eCollection 2018.

3.

Comparative Effectiveness and Safety of Bariatric Procedures for Weight Loss: A PCORnet Cohort Study.

Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Murali S, Williams N, Coleman KJ, Courcoulas A, Coley RY, Anau J, Pardee R, Toh S, Janning C, Cook A, Sturtevant J, Horgan C, McTigue KM; PCORnet Bariatric Study Collaborative.

Ann Intern Med. 2018 Dec 4;169(11):741-750. doi: 10.7326/M17-2786. Epub 2018 Oct 30.

PMID:
30383139
4.

Early Antibiotic Exposure and Weight Outcomes in Young Children.

Block JP, Bailey LC, Gillman MW, Lunsford D, Daley MF, Eneli I, Finkelstein J, Heerman W, Horgan CE, Hsia DS, Jay M, Rao G, Reynolds JS, Rifas-Shiman SL, Sturtevant JL, Toh S, Trasande L, Young J, Forrest CB; PCORnet Antibiotics and Childhood Growth Study Group.

Pediatrics. 2018 Dec;142(6). pii: e20180290. doi: 10.1542/peds.2018-0290. Epub 2018 Oct 31. Erratum in: Pediatrics. 2019 Feb;143(2):.

PMID:
30381474
5.

Comparative effectiveness of bariatric procedures among adolescents: the PCORnet bariatric study.

Inge TH, Coley RY, Bazzano LA, Xanthakos SA, McTigue K, Arterburn D, Williams N, Wellman R, Coleman KJ, Courcoulas A, Desai NK, Anau J, Pardee R, Toh S, Janning C, Cook A, Sturtevant J, Horgan C, Zebrick AJ, Michalsky M; PCORnet Bariatric Study Collaborative.

Surg Obes Relat Dis. 2018 Sep;14(9):1374-1386. doi: 10.1016/j.soard.2018.04.002. Epub 2018 Apr 17.

6.

Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis.

Lu CY, Penfold RB, Toh S, Sturtevant JL, Madden JM, Simon G, Ahmedani BK, Clarke G, Coleman KJ, Copeland LA, Daida YG, Davis RL, Hunkeler EM, Owen-Smith A, Raebel MA, Rossom R, Soumerai SB, Kulldorff M.

Med Care. 2018 May;56(5):365-372. doi: 10.1097/MLR.0000000000000893.

7.

PCORnet Antibiotics and Childhood Growth Study: Process for Cohort Creation and Cohort Description.

Block JP, Bailey LC, Gillman MW, Lunsford D, Boone-Heinonen J, Cleveland LP, Finkelstein J, Horgan CE, Jay M, Reynolds JS, Sturtevant JL, Forrest CB; PCORnet Antibiotics Childhood Growth Study Group.

Acad Pediatr. 2018 Jul;18(5):569-576. doi: 10.1016/j.acap.2018.02.008. Epub 2018 Mar 15.

8.

The National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study Cohort: Rationale, Methods, and Baseline Characteristics.

Toh S, Rasmussen-Torvik LJ, Harmata EE, Pardee R, Saizan R, Malanga E, Sturtevant JL, Horgan CE, Anau J, Janning CD, Wellman RD, Coley RY, Cook AJ, Courcoulas AP, Coleman KJ, Williams NA, McTigue KM, Arterburn D, McClay J; PCORnet Bariatric Surgery Collaborative.

JMIR Res Protoc. 2017 Dec 5;6(12):e222. doi: 10.2196/resprot.8323.

9.

Effect of body surface decolonisation on bacteriuria and candiduria in intensive care units: an analysis of a cluster-randomised trial.

Huang SS, Septimus E, Hayden MK, Kleinman K, Sturtevant J, Avery TR, Moody J, Hickok J, Lankiewicz J, Gombosev A, Kaganov RE, Haffenreffer K, Jernigan JA, Perlin JB, Platt R, Weinstein RA; Agency for Healthcare Research and Quality (AHRQ) DEcIDE Network and Healthcare-Associated Infections Program, and the CDC Prevention Epicenters Program.

Lancet Infect Dis. 2016 Jan;16(1):70-79. doi: 10.1016/S1473-3099(15)00238-8. Epub 2015 Nov 27.

10.

Vocation, location, vocation: researching Candida pathogenesis.

Sturtevant J.

Virulence. 2014;5(8):773-4. doi: 10.4161/21505594.2014.973806. No abstract available.

11.

Dabigatran may not be an effective anticoagulant for haemodialysis.

Cho Y, Mills K, Sturtevant JM, Pillans PI, Mudge DW.

Nephrology (Carlton). 2010 Aug;15(5):594-5. doi: 10.1111/j.1440-1797.2010.01347.x. No abstract available.

PMID:
20649885
12.

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).

Barraclough KA, Noble E, Leary D, Brown F, Hawley CM, Campbell SB, Isbel NM, Mudge DW, van Eps CL, Sturtevant JM, Johnson DW.

BMC Nephrol. 2009 Jul 28;10:20. doi: 10.1186/1471-2369-10-20.

13.

Off-label use of rituximab in a tertiary Queensland hospital.

Butterly SJ, Pillans P, Horn B, Miles R, Sturtevant J.

Intern Med J. 2010 Jun;40(6):443-52. doi: 10.1111/j.1445-5994.2009.01988.x. Epub 2009 May 21.

PMID:
19460062
14.

N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain.

Yelland MJ, Poulos CJ, Pillans PI, Bashford GM, Nikles CJ, Sturtevant JM, Vine N, Del Mar CB, Schluter PJ, Tan M, Chan J, Mackenzie F, Brown R.

Pain Med. 2009 May-Jun;10(4):754-61. doi: 10.1111/j.1526-4637.2009.00615.x. Epub 2009 Apr 22.

PMID:
19453961
15.

Bmh1p (14-3-3) mediates pathways associated with virulence in Candida albicans.

Kelly MN, Johnston DA, Peel BA, Morgan TW, Palmer GE, Sturtevant JE.

Microbiology. 2009 May;155(Pt 5):1536-46. doi: 10.1099/mic.0.027532-0. Epub 2009 Apr 16. Erratum in: Microbiology. 2009 Jun;155(Pt 6):2112.

16.

Role for endosomal and vacuolar GTPases in Candida albicans pathogenesis.

Johnston DA, Eberle KE, Sturtevant JE, Palmer GE.

Infect Immun. 2009 Jun;77(6):2343-55. doi: 10.1128/IAI.01458-08. Epub 2009 Apr 13.

17.

Effect of environmental factors on the spatio-temporal patterns of influenza spread.

Charland KM, Buckeridge DL, Sturtevant JL, Melton F, Reis BY, Mandl KD, Brownstein JS.

Epidemiol Infect. 2009 Oct;137(10):1377-87. doi: 10.1017/S0950268809002283. Epub 2009 Mar 19.

PMID:
19296868
18.

Reporter gene assays in Candida albicans.

Sturtevant J.

Methods Mol Biol. 2009;499:157-67. doi: 10.1007/978-1-60327-151-6_15.

PMID:
19152047
19.

The new International Health Regulations: considerations for global public health surveillance.

Sturtevant JL, Anema A, Brownstein JS.

Disaster Med Public Health Prep. 2007 Nov;1(2):117-21. doi: 10.1097/DMP.0b013e318159cbae.

PMID:
18388639
20.

Candida albicans adhesins: Biochemical aspects and virulence.

Sturtevant J, Calderone R.

Rev Iberoam Micol. 1997 Sep;14(3):90-7.

21.

Autophagy in the pathogen Candida albicans.

Palmer GE, Kelly MN, Sturtevant JE.

Microbiology. 2007 Jan;153(Pt 1):51-8.

PMID:
17185534
22.

Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.

Sturtevant JM, Pillans PI, Mackenzie F, Gibbs HH.

Intern Med J. 2006 Jul;36(7):431-6.

PMID:
16780449
23.

A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.

Kaisar MO, Wiggins KJ, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Mudge DW, Bofinger A, Petrie JJ, Johnson DW.

Am J Kidney Dis. 2006 May;47(5):809-14.

PMID:
16632019
24.

The Candida albicans vacuole is required for differentiation and efficient macrophage killing.

Palmer GE, Kelly MN, Sturtevant JE.

Eukaryot Cell. 2005 Oct;4(10):1677-86.

25.

Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders.

Sturtevant JM, Hawley CM, Reiger K, Johnson DW, Campbell SB, Burke JR, Bofinger A, Isbel NM.

Nephrology (Carlton). 2004 Dec;9(6):406-13.

PMID:
15663645
26.

Random mutagenesis of an essential Candida albicans gene.

Palmer GE, Sturtevant JE.

Curr Genet. 2004 Dec;46(6):343-56. Epub 2004 Nov 10.

PMID:
15549319
27.

Meeting report: Candida and Candidiasis.

Sturtevant J.

Mycopathologia. 2004 Jul;158(1):141-6. No abstract available.

PMID:
15487332
28.

Mutant alleles of the essential 14-3-3 gene in Candida albicans distinguish between growth and filamentation.

Palmer GE, Johnson KJ, Ghosh S, Sturtevant J.

Microbiology. 2004 Jun;150(Pt 6):1911-24.

PMID:
15184577
29.

An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

Fidel PL Jr, Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, Quayle AJ, Dunlap K.

Infect Immun. 2004 May;72(5):2939-46.

30.

The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial.

Mudge DW, Atcheson B, Taylor PJ, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Nicol DL, Pillans PI, Johnson DW.

Transplantation. 2004 Jan 27;77(2):206-9.

PMID:
14742982
31.

Metformin and serious adverse effects.

Nisbet JC, Sturtevant JM, Prins JB.

Med J Aust. 2004 Jan 19;180(2):53-4.

PMID:
14723582
32.

Predictors of decline of residual renal function in new peritoneal dialysis patients.

Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P.

Perit Dial Int. 2003 May-Jun;23(3):276-83.

PMID:
12938830
33.

Candida albicans VPS11 is required for vacuole biogenesis and germ tube formation.

Palmer GE, Cashmore A, Sturtevant J.

Eukaryot Cell. 2003 Jun;2(3):411-21.

34.

Evaluation of dosage adjustment in patients with renal impairment.

Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM.

Intern Med J. 2003 Jan-Feb;33(1-2):10-3. Erratum in: Intern Med J. 2003 Jul;33(7):331.

PMID:
12534872
35.

Translation elongation-3-like factors: are they rational antifungal targets?

Sturtevant J.

Expert Opin Ther Targets. 2002 Oct;6(5):545-53. Review.

PMID:
12387678
36.

The Candida albicans 14-3-3 gene, BMH1, is essential for growth.

Cognetti D, Davis D, Sturtevant J.

Yeast. 2002 Jan 15;19(1):55-67.

37.

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, Sturtevant JM, Isbel NM, Nicol DL, Johnson DW.

J Am Soc Nephrol. 2001 Apr;12(4):814-21.

38.

Beneficial effects of a hospital bereavement intervention program after traumatic childhood death.

Oliver RC, Sturtevant JP, Scheetz JP, Fallat ME.

J Trauma. 2001 Mar;50(3):440-6; discussion 447-8.

PMID:
11265051
39.
40.

Treatment of peritoneal dialysis related peritonitis.

Johnson DW, Looke D, Sturtevant JM.

Aust N Z J Med. 2000 Feb;30(1):97-8. No abstract available.

PMID:
10800893
41.

Sidechain interactions in parallel beta sheets: the energetics of cross-strand pairings.

Merkel JS, Sturtevant JM, Regan L.

Structure. 1999 Nov 15;7(11):1333-43.

43.

Identification and cloning of GCA1, a gene that encodes a cell surface glucoamylase from Candida albicans.

Sturtevant J, Dixon F, Wadsworth E, Latge JP, Zhao XJ, Calderone R.

Med Mycol. 1999 Oct;37(5):357-66.

PMID:
10520161
44.

Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicans.

Muhlschlegal F, Fonzi W, Hoyer L, Payne T, Poulet FM, Clevenger J, Latgé JP, Calera J, Beauvais A, Paris S, Monod M, Sturtevant J, Ghannoum M, Nozawa Y, Calderone R.

Med Mycol. 1998;36 Suppl 1:238-48. Review.

PMID:
9988513
45.

Structure of the capsid of Pf3 filamentous phage determined from X-ray fibre diffraction data at 3.1 A resolution.

Welsh LC, Symmons MF, Sturtevant JM, Marvin DA, Perham RN.

J Mol Biol. 1998;283(1):155-77.

PMID:
9761681
46.

Disruption studies of a Candida albicans gene, ELF1: a member of the ATP-binding cassette family.

Sturtevant J, Cihlar R, Calderone R.

Microbiology. 1998 Aug;144 ( Pt 8):2311-21.

PMID:
9720054
47.

A differential scanning calorimetric study of the thermal unfolding of apo- and holo-cytochrome b562.

Robinson CR, Liu Y, O'Brien R, Sligar SG, Sturtevant JM.

Protein Sci. 1998 Apr;7(4):961-5.

48.
49.

Energetics of heme binding to native and denatured states of cytochrome b562.

Robinson CR, Liu Y, Thomson JA, Sturtevant JM, Sligar SG.

Biochemistry. 1997 Dec 23;36(51):16141-6.

PMID:
9405047
50.

The adaptability of Escherichia coli thioredoxin to non-conservative amino acid substitutions.

O'Brien R, Wynn R, Driscoll PC, Davis B, Plaxco KW, Sturtevant JM, Ladbury JE.

Protein Sci. 1997 Jun;6(6):1325-32.

Supplemental Content

Loading ...
Support Center